Correlation Between AbbVie and Cocrystal Pharma
Can any of the company-specific risk be diversified away by investing in both AbbVie and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Cocrystal Pharma, you can compare the effects of market volatilities on AbbVie and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Cocrystal Pharma.
Diversification Opportunities for AbbVie and Cocrystal Pharma
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AbbVie and Cocrystal is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of AbbVie i.e., AbbVie and Cocrystal Pharma go up and down completely randomly.
Pair Corralation between AbbVie and Cocrystal Pharma
Given the investment horizon of 90 days AbbVie is expected to generate 8.15 times less return on investment than Cocrystal Pharma. But when comparing it to its historical volatility, AbbVie Inc is 4.19 times less risky than Cocrystal Pharma. It trades about 0.04 of its potential returns per unit of risk. Cocrystal Pharma is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 176.00 in Cocrystal Pharma on September 13, 2024 and sell it today you would earn a total of 12.00 from holding Cocrystal Pharma or generate 6.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AbbVie Inc vs. Cocrystal Pharma
Performance |
| Timeline |
| AbbVie Inc |
| Cocrystal Pharma |
AbbVie and Cocrystal Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and Cocrystal Pharma
The main advantage of trading using opposite AbbVie and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.| AbbVie vs. Puma Biotechnology | AbbVie vs. Iovance Biotherapeutics | AbbVie vs. Sarepta Therapeutics | AbbVie vs. Day One Biopharmaceuticals |
| Cocrystal Pharma vs. RenovoRx | Cocrystal Pharma vs. Tempest Therapeutics | Cocrystal Pharma vs. Ikena Oncology | Cocrystal Pharma vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |